Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherShares Issued
Ratios

Barinthus Biotherapeutics (BRNS) Preferred Shares Issued (2021)

Barinthus Biotherapeutics' Preferred Shares Issued history spans 1 years, with the latest figure at $125.2 million for Q1 2021.

  • For Q1 2021, Preferred Shares Issued changed N/A year-over-year to $125.2 million; the TTM value through Dec 2021 reached $125.2 million, changed N/A, while the annual FY2021 figure was $125.2 million, N/A changed from the prior year.
  • Preferred Shares Issued reached $125.2 million in Q1 2021 per BRNS's latest filing.
  • In the past five years, Preferred Shares Issued ranged from a high of $125.2 million in Q1 2021 to a low of $125.2 million in Q1 2021.